Home › Parkinson's Disease › Ohio › Columbus
Parkinson's Disease clinical trials in Columbus, OH
6 studies for Parkinson's Disease are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Buntanetap in Participants With PD
RecruitingPhase 2/3
- The Ohio State University Wexner Medical Center, Columbus
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
RecruitingObservational study
- Ohio State University, Columbus
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
RecruitingPhase 2
- The Ohio State University Wexner Medical Center (site #207), Columbus
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RecruitingPhase 2
- The Ohio State University, Columbus
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
RecruitingObservational study
- Ohio State Medical, Columbus
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
RecruitingObservational study
- The Ohio State University, Columbus
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA20 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN16 studies
- San Francisco, CA15 studies
- Philadelphia, PA15 studies
- Miami, FL14 studies
- Farmington Hills, MI14 studies
- New Haven, CT14 studies
- Chicago, IL14 studies
- Gainesville, FL13 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer54 studies
- Ovarian Cancer40 studies
- Breast Cancer39 studies
- Cancer (all types)39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Endometrial Cancer26 studies
- Metastatic Cancer26 studies
- Multiple Myeloma24 studies
- Prostate Cancer24 studies
- Colorectal Cancer23 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.